Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹9,719 Cr
Revenue (TTM)
₹1,007 Cr
Net Profit (TTM)
₹159 Cr
ROE
7.7 %
ROCE
11.8 %
P/E Ratio
61.2
P/B Ratio
7.4
Industry P/E
38.68
EV/EBITDA
38.1
Div. Yield
0.1 %
Debt to Equity
--
Book Value
₹160
EPS
₹31.1
Face value
5
Shares outstanding
81,868,922
CFO
₹249.70 Cr
EBITDA
₹599.65 Cr
Net Profit
₹356.00 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
AMI Organics
| 11.3 | 9.1 | 6.8 | 97.7 | 35.6 | -- | -- |
|
BSE Healthcare
| -6.1 | 0.3 | 7.1 | 18.4 | 22.8 | 22.3 | 9.5 |
|
BSE Small Cap
| -6.1 | 4.7 | 12.2 | 7.3 | 25.0 | 37.4 | 16.5 |
|
Company
|
2024
|
2023
|
2022
|
|---|---|---|---|
|
AMI Organics
| 87.8 | 16.2 | -9.6 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
AMI Organics
|
1,195.9 | 9,719.1 | 1,006.9 | 160.4 | 20.4 | 12.6 | 61.2 | 7.4 |
| 866.7 | 7,912.4 | 2,115.1 | 272.4 | 17.8 | 14.2 | 29 | 4.0 | |
| 569.2 | 8,879.4 | 4,178.2 | 0.8 | -- | 0.1 | -- | 3.1 | |
| 515.3 | 12,516.5 | 4,460.0 | 479.1 | 16.4 | 14.4 | 26.1 | 3.5 | |
| 409.0 | 5,007.2 | 1,859.8 | 90.8 | 10.4 | 7.4 | 55.1 | 4.0 | |
| 872.2 | 4,961.4 | 1,243.7 | 128.3 | 13.0 | 13.8 | 38.7 | 5.2 | |
| 982.0 | 2,370.3 | 356.3 | 100.9 | 25.0 | 13.3 | 23.5 | 3.0 | |
| 262.6 | 2,327.1 | 780.4 | 63.4 | 12.6 | 12 | 35.2 | 3.8 | |
| 160.3 | 5,273.5 | 71.8 | -342.5 | -467.5 | -- | -- | -24.3 | |
| 990.6 | 2,936.8 | 245.3 | -50.8 | -18.5 | -40.5 | -- | 9.8 |
3 min read•By Udhayaprakash
Ami Organics IPO: Information analysis
6 min read•By Danish Khanna and Udhayaprakash
Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical... ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation, salicylic acid, and other special chemicals that are used in cosmetics, dyes, polymers and agrochemical, animal foods, and personal care industries. Ami Organics Limited exports its products. The company was founded in 2004 and is based in Surat, India. Read more
Incorporated
2007
Chairman
Nareshkumar Patel
Managing Director
Nareshkumar Patel
Headquarters
Surat, Gujarat
Website
Looking for more details about AMI Organics Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of AMI Organics Ltd stood at ₹ 1,549 Cr as on 31-Mar-25
The share price of AMI Organics Ltd is ₹1,195.90 (NSE) and ₹1,195.25 (BSE) as of 23-May-2025 11:09 IST. AMI Organics Ltd has given a return of 35.62% in the last 3 years.
AMI Organics Ltd has a market capitalisation of ₹ 9,719 Cr as on 23-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of AMI Organics Ltd is 7.42 times as on 23-May-2025, a 87% premium to its peers’ median range of 3.97 times.
The P/E ratio of AMI Organics Ltd is 61.24 times as on 23-May-2025, a 58% premium to its peers’ median range of 38.68 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the AMI Organics Ltd and enter the required number of quantities and click on buy to purchase the shares of AMI Organics Ltd.
Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation, salicylic acid, and other special chemicals that are used in cosmetics, dyes, polymers and agrochemical, animal foods, and personal care industries. Ami Organics Limited exports its products. The company was founded in 2004 and is based in Surat, India.
The promoters of AMI Organics Ltd are Nareshkumar Ramjibhai Patel and Vaghasia Chetankumar Chhaganlal. They collectively own 35.96 per cent of the total equity. The chairman of the company is Nareshkumar Patel
There is no promoter pledging in AMI Organics Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
12,274
|
|
|
8,602
|
|
|
7,219
|
|
|
5,277
|
|
|
5,231
|
|
|
4,794
|
|
|
2,875
|
|
|
2,299
|
|
|
2,147
|
| AMI Organics Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
12.64
|
|
Operating margin(%)
|
20.4
|
|
Net Margin(%)
|
15.67
|
|
Dividend yield(%)
|
0.06
|
Yes, TTM profit after tax of AMI Organics Ltd was ₹159 Cr.
₹7.30
(
